NeuroPace Files Definitive Proxy Statement
Ticker: NPCE · Form: DEF 14A · Filed: Apr 22, 2025 · CIK: 1528287
| Field | Detail |
|---|---|
| Company | Neuropace Inc (NPCE) |
| Form Type | DEF 14A |
| Filed Date | Apr 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
NeuroPace proxy filed - vote your shares!
AI Summary
NeuroPace Inc. filed its definitive proxy statement on April 22, 2025, for its annual meeting on June 6, 2025. The filing concerns the election of directors and other corporate governance matters. The company is headquartered at 455 N. Bernardo Avenue, Mountain View, CA.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership and voting matters ahead of the annual meeting, impacting corporate governance and strategic direction.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual meeting, not indicating immediate financial distress or significant new risks.
Key Numbers
- 20250606 — Annual Meeting Date (Shareholders will vote on proposals at this date.)
- 20250422 — Filing Date (The proxy statement was filed on this date.)
Key Players & Entities
- NeuroPace Inc (company) — Registrant
- 455 N. Bernardo Avenue, Mountain View, CA (location) — Company Address
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the annual meeting, including details on director elections and other corporate governance matters.
When is the NeuroPace Inc. annual meeting scheduled?
The annual meeting is scheduled for June 6, 2025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 22, 2025.
Where is NeuroPace Inc. headquartered?
NeuroPace Inc. is headquartered at 455 N. Bernardo Avenue, Mountain View, CA.
What is the SEC file number for NeuroPace Inc. under the 1934 Act?
The SEC file number is 001-40337.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 22, 2025 regarding NeuroPace Inc (NPCE).